Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.
about
Human recombinant activated protein C for severe sepsisHuman recombinant protein C for severe sepsis and septic shock in adult and paediatric patientsHuman recombinant activated protein C for severe sepsisDrotrecogin alfa (activated): the first FDA-approved treatment for severe sepsisThrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirementsSevere sepsis: variation in resource and therapeutic modality use among academic centersAssessment of six mortality prediction models in patients admitted with severe sepsis and septic shock to the intensive care unit: a prospective cohort studyEffects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat modelPrevalence and incidence of severe sepsis in Dutch intensive care unitsEpidemiology of sepsis in Norway in 1999Brazilian Sepsis Epidemiological Study (BASES study)Severe sepsis epidemiology: sampling, selection, and societyTLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxinsUniversal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illnessRenal blood flow in sepsis: a complex issue.Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISEDeveloping a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Unrevealing culture-negative severe sepsisTowards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectEvaluation of vitamin C for adjuvant sepsis therapyProcalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysisEpidemiology of severe infections in Latin American intensive care unitsIL-1β, IL-6, and RANTES as Biomarkers of Chikungunya SeverityEpidemiologic trends of sepsis in western countriesEchocardiography practice, training and accreditation in the intensive care: document for the World Interactive Network Focused on Critical Ultrasound (WINFOCUS)Hyperresponsiveness of mice deficient in plasma-secreted sphingomyelinase reveals its pivotal role in early phase of host responseDrotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis.Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically illIntensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failureA Case of Thrombocytopenia due to Odontogenic Infection.The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study.A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department usersIncidence and predictive risk factors of postoperative sepsis in orthopedic trauma patients.Hypothermia predicts mortality in critically ill elderly patients with sepsisThe epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study.Timing of renal replacement therapy: is it when or how much?Mortality and quality of life in the five years after severe sepsisCharacteristics and outcomes of culture-negative versus culture-positive severe sepsis.
P2860
Q24201123-FCD6A62D-31E1-4574-85BC-6E76C33C536DQ24202128-03239293-3B37-4002-BE87-CAB515CAA15DQ24235181-49F69F8E-45D7-4C97-8AA9-77256A013D26Q24536981-F73FB789-6CD2-4041-8D08-3999E3F645F1Q24794504-B1142E63-C17F-46FF-95A1-37E36A3AEB57Q24794938-EB6FCD19-91F1-438A-9038-BEEE56A6133AQ24796183-871D120F-A137-48E0-B2A6-751E6B9FE48FQ24797978-B9BF6A05-88DA-4C42-AEC0-58E617033125Q24800391-6618433D-ED74-45BF-A6CE-1B408E345729Q24800567-BCF7DCDD-4A7C-49CE-A86C-E49F2EF6D31CQ24801014-2C6A55FF-333B-44F2-B2DB-608719BE9DADQ24801309-A3C27EDF-7359-4AE4-B801-AE04B1479CD6Q24805246-BE87979D-C8E5-40E2-B5DE-1A00DE0DF428Q24805414-C8D5C124-2620-43AF-81F3-EA09062851E6Q24805539-920A811F-C0DE-4049-AB04-4AED0C74205BQ24810779-8CA3C2BA-ACEA-49FB-AF8B-F9EC00640977Q26745899-CD206747-F960-495E-8C7C-00C4763C6EB7Q26768292-00EF31A1-B96C-4BCE-8EDF-F2F8DF0C289DQ26830520-4182F8FC-C334-4FFC-8BCC-AEA21BD7B0DEQ26996658-A42E052D-D143-4E05-A79B-08D2E6639EACQ27026804-7B3137EB-B426-4467-A978-DFB983141953Q27028085-AEFB9E80-C978-473A-8AA0-62262DAD5ED7Q27468988-9A35FF4A-1D1E-4028-B3E4-317402725784Q27487567-D837624C-98BE-4C15-9075-7ABA6C7E69B4Q28072231-B61488E8-D4DE-40DE-8A99-82993AD2A87FQ30484722-9B5AC619-394B-4D33-9824-9511FC41B448Q30531999-D3F0F628-14F1-4A4E-84C0-1B36195C6635Q30788622-847D11B5-3EDA-48BA-A0E3-BEAD21C40BE3Q33316403-E24067E1-9151-4CB9-AF3D-5BDA60AF97C6Q33373238-86C6CE39-AFC4-48BD-B6F2-E96DD5FAEB8BQ33381364-31DE4FD5-2F8C-42E9-B9EC-747341A8F4AAQ33403404-36AA8EDE-84BD-479D-9410-B87265AFF1ADQ33589699-32467266-615C-405D-9A16-4F0E0ED7317DQ33606193-0D147E82-1D98-49C9-90B2-418212C405BFQ33676305-986683EF-A806-4310-B977-38FECE31C81EQ33704452-7FCDC466-6120-4D09-BA39-BB2ED388CCC3Q33752807-761F2478-87A5-4D67-8950-E168DEA3C187Q33753842-778DCB62-BEF9-49FA-AAA4-32480CC85D12Q33754061-2F9E3394-A375-4381-BC26-525004508334Q33754440-4CACFCBF-31E5-46E7-A000-EC6B2C3246F2
P2860
Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Incidence, risk factors, and o ...... h ICU Group for Severe Sepsis.
@ast
Incidence, risk factors, and o ...... h ICU Group for Severe Sepsis.
@en
type
label
Incidence, risk factors, and o ...... h ICU Group for Severe Sepsis.
@ast
Incidence, risk factors, and o ...... h ICU Group for Severe Sepsis.
@en
prefLabel
Incidence, risk factors, and o ...... h ICU Group for Severe Sepsis.
@ast
Incidence, risk factors, and o ...... h ICU Group for Severe Sepsis.
@en
P2093
P921
P1476
Incidence, risk factors, and o ...... h ICU Group for Severe Sepsis.
@en
P2093
A Lepoutre
C Brun-Buisson
G Offenstadt
J C Mercier
P Dellamonica
P304
P356
10.1001/JAMA.1995.03530120060042
P407
P577
1995-09-01T00:00:00Z